Use of Traditional Chinese Herbal Medicine Concurrently with Conventional Cancer Treatment Among Chinese Cancer Patients

Objective.We evaluated the efficiency of traditional Chinese herbal medicine (a compound herbal formula for invigorating spleen) as a complementary and alternative therapy for gastric cancer patients with peritoneal metastasis.Methods.Between 2001 and 2012, 93 gastric cancer patients with peritoneal metastasis were enrolled in this study. The effect of traditional Chinese herbal medicine on their long-term outcome was investigated. Kaplan-Meier method was used to assess the difference in survival time, and Cox proportional hazards regression analysis was performed to identify independent prognostic factors.Result.First-line palliative chemotherapy plus traditional Chinese herbal medicine was performed in 47 patients and the other 46 patients received chemotherapy alone. The overall survival was different between patients with and without traditional Chinese herbal medicine (12.0 versus 10.5 months;P=0.046). According to the Cox proportional hazard model, first-line chemotherapy cycle (hazards ratio [HR] = 0.527; 95% CI = 0.323~0.860) and TCHM (hazards ratio [HR] = 0.644; 95% CI = 0.481~0.992) were selected as independent prognostic factors for survival.Conclusion.The results suggest that traditional Chinese herbal medicine could improve the prognosis of the gastric cancer patients with peritoneal metastasis.

Download Full-text

Traditional Chinese herbal medicine and its effects on the quality of life of lung cancer patients: a meta-analysis

Bioscience Horizons The International Journal of Student Research ◽

10.1093/biohorizons/hzx018 ◽

2017 ◽

Vol 10 ◽

Author(s):

Amy Stewart

Keyword(s):

Quality Of Life ◽

Lung Cancer ◽

Herbal Medicine ◽

Cancer Patients ◽

Chinese Herbal Medicine ◽

Meta Analysis ◽

Traditional Chinese Herbal Medicine ◽

Lung Cancer Patients ◽

Chinese Herbal

Download Full-text

Survival Analysis of Traditional Chinese Herbal Medicine Spleen-invigorating Compound in Patients with Pancreatic cancer

10.21203/rs.3.rs-23172/v1 ◽

2020 ◽

Author(s):

Xin Li ◽

Ling Chen ◽

Xiaoqiang Gu ◽

Jiahua Xu ◽

Hongwei Li ◽

...

Keyword(s):

Pancreatic Cancer ◽

Overall Survival ◽

Prognostic Factors ◽

Herbal Medicine ◽

Survival Time ◽

Cancer Patients ◽

Chinese Herbal Medicine ◽

Median Overall Survival ◽

Traditional Chinese Herbal Medicine ◽

Chinese Herbal

Abstract Background Traditional Chinese herbal medicine (TCHM) is widely used in the treatment of pancreatic cancer in China. In this retrospective study, the authors mainly analyzed the effect of TCHM on the survival time of patients with pancreatic cancer. Methods From 2011 to 2018, 121 pancreatic cancer patients were enrolled in this study. All patients were divided into either the TCHM group or non-TCHM group based on received TCHM or not. TCHM group received three months or more of TCHM treatment on the basis of comprehensive treatment. Kaplan-Meier method was used to assess the difference in survival time, and Cox proportional hazards regression analysis was performed to identify independent prognostic factors. Results The overall survival was different between all patients with and without TCHM (P = 0.000), COX analysis showed the clinical staging (P = 0.050), surgery (P = 0.000), chemotherapy (P = 0.000) and TCHM (P = 0.000) were independent prognostic factors. In a stratification analysis of stage for patients who received chemotherapy, there was a significant increase in median overall survival from 10.7 (non-TCHM group) to 19.5 (TCHM group) months (hazard ratio [HR] = 3.197, 95% confidence interval [CI] 1.989–5.137, P = 0.000). Patients who did not receive chemotherapy, but best supportive care, there was a significant increase in median overall survival from 4.3 (non-TCHM group) to 15.1 (TCHM group) months (HR = 0.041, 95% CI = 0.005–0.329, P = 0.003). Conclusions TCHM was an important independent prognostic factor of pancreatic cancer and have an effect on improving the prognosis of pancreatic cancer patients.

Download Full-text

Utilization of and Attitudes towards Traditional Chinese Medicine Therapies in a Chinese Cancer Hospital: A Survey of Patients and Physicians

Evidence-based Complementary and Alternative Medicine ◽

10.1155/2012/504507 ◽

2012 ◽

Vol 2012 ◽

pp. 1-11 ◽

Cited By ~ 33

Author(s):

Jennifer L. McQuade ◽

ZhiQiang Meng ◽

Zhen Chen ◽

Qi Wei ◽

Ying Zhang ◽

...

Keyword(s):

Chinese Medicine ◽

Herbal Medicine ◽

Traditional Chinese Medicine ◽

Immune Function ◽

Cancer Patients ◽

Chinese Herbal Medicine ◽

Cancer Care ◽

Cancer Center ◽

Chinese Herbal ◽

Chinese Cancer Patients

Background. In China, the use of traditional Chinese medicine (TCM) is very popular, but little is known about how it is integrated with conventional cancer care. We conducted parallel surveys of patients and physicians on TCM utilization.Methods. Two hundred forty-five patients and 72 allopathic physicians at the Fudan University Shanghai Cancer Center completed questions on their use of and attitude towards TCM.Results. Patient mean age was 51, with 60% female. Eighty-three percent of patients had used TCM. Use was greatest for Chinese herbal medicine (CHM; 55.8%). Only 1.3% of patients used acupuncture and 6.8% Qi Gong or Tai Qi. Sixty-three percent of patients notified their oncologist about TCM use. The most common reason for use was to improve immune function. CHM was often used with a goal of treating cancer (66.4%), a use that 57% of physicians agreed with. Physicians were most concerned with interference with treatment, lack of evidence, and safety. Ninety percent of physicians have prescribed herbs and 87.5% have used TCM themselves.Conclusion. The use of TCM by Chinese cancer patients is exceptionally high, and physicians are generally well informed and supportive of patients’ use. Botanical agents are much more commonly used than acupuncture or movement-based therapies.

Download Full-text